The Comprehensive Cancer Control Joint Action (CANCON) will pick up where the recently ended European Partnership for Action Against Cancer (EPAAC) left off. It will cover many of the same areas, but with a greater [more]
Building a lung cancer team that works seamlessly to do the best for each patient was the biggest challenge in Enriqueta Felips career. Her focus today is on increasing collaboration across Europe, which she sees [more]
The debilitating impact neurotoxic drugs can have on patients long-term quality of life has been systematically underestimated. Can oncologists do more to pick up potential symptoms before they become irreversible? Cancer patients about to start [more]
Christiane Hawranek and Marco Maurer, freelance print and radio journalists, won a Best Cancer Reporter Award for their exposé of the agencies that exploit foreign patients seeking treatment for cancer and other serious conditions. They [more]
People do better throughout their cancer journey when their physical, psychological and spiritual care needs are attended to. But how do we overcome entrenched mind sets that still resist integrating palliative and oncologic care? Philip [more]
The recently concluded Partnership programme marked the first time that EU member states have taken a joint approach to improving cancer plans and the organisation of services. Was it a worthwhile exercise? And where do [more]
EORTC boosts efforts to address the long-term problems faced by people who have been treated for cancer. The number of people who are living long lives after cancer treatment has been rising year on year, [more]
Modern tools of biological investigation give us opportunities to develop drugs much more efficiently. The president of Europes most important trials organisation explains how these opportunities can and must be exploited to start [more]
For cancer therapies to succeed, induction of an anticancer immune response is required. Immuno-oncology approaches are shaping the treatment landscape for patients with advanced-stage melanoma and other solid tumours. These new approaches may enhance immune [more]